ContractDevelopment Collaboration Agreement • November 21st, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
This DEVELOPMENT COLLABORATION Agreement (the "Agreement") dated as of September 30, 2016 (the "Effective Date") is entered into by and between Moleculin Biotech, Inc. ("MBI"), a Delaware corporation, having a business address of 2575 West Bellfort Dr., Suite 333, Houston, TX 77054 and Dennin Sp. z o. o. a limited liability company having a principal place of business located at PL-00-116 Warszawa, ul. Switokrzyska 30/63, Poland ("Dermin"). MBI and Dermin are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
